With more data on its COVID-19 vaccine, Russian institute offers new evidence of success – Science News release: SECOND interim analysis of clinical trial data showed a 91.4% efficacy for the Sputnik V vaccine on day 28 after the first dose; vaccine efficacy is over 95% 42 days after the first dose – Sputnik V […]

The post With more data on its COVID-19 vaccine, Russian institute offers new evidence of success appeared first on Links Medicus.